Bluesky Facebook Reddit Email

Symptom-based dosing for neonatal opioid withdrawal

04.25.26 | JAMA Network

SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

About The Study: This randomized clinical trial found that symptom-based dosing decreased time to medical readiness for discharge compared with a scheduled opioid taper approach among infants with opioid withdrawal cared for with Eat, Sleep, Console.

Corresponding Author: To contact the corresponding author, Lori A. Devlin, DO, email lori.devlinphinney@louisville.edu .

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2026.5782)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Media advisory: This study is being presented at the annual Pediatric Academic Societies meeting.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2026.5782?guestAccessKey=216997b4-05d9-49a5-b39a-7c039273e7d2&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=042526

JAMA

Keywords

Article Information

Contact Information

JAMA Network Media Relations
JAMA Network
mediarelations@jamanetwork.org

How to Cite This Article

APA:
JAMA Network. (2026, April 25). Symptom-based dosing for neonatal opioid withdrawal. Brightsurf News. https://www.brightsurf.com/news/L3RP9YY8/symptom-based-dosing-for-neonatal-opioid-withdrawal.html
MLA:
"Symptom-based dosing for neonatal opioid withdrawal." Brightsurf News, Apr. 25 2026, https://www.brightsurf.com/news/L3RP9YY8/symptom-based-dosing-for-neonatal-opioid-withdrawal.html.